Citation Tools

Download PDFPDF

440 Activity and safety of camrelizumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced non-small-cell lung cancer

Download to a citation manager

Cite this article as:
Sun GG, Jia JH, Gao P, et al
440 Activity and safety of camrelizumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced non-small-cell lung cancer